⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5005529 | 0.80 | — | — | |
| SCHEMBL29146 | 0.76 | — | — | |
| SCHEMBL28427971 | 0.73 | — | — | |
| Water SCHEMBL27495819 | 0.73 | — | — | |
| SCHEMBL8857028 | 0.73 | — | — | |
| SCHEMBL5609357 | 0.73 | — | — | |
| SCHEMBL838299 | 0.70 | — | — | |
| SCHEMBL2341763 | 0.70 | — | — | |
| SCHEMBL839019 | 0.67 | — | — | |
| SCHEMBL336868 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029226-A1 | METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES | DSM IP ASSETS B.V. (NL) | 2012-02-02 | — | — | US | claimed |
| US-8273726-B2 | Compositions for treating and/or preventing diseases characterized by the presence of metal ions | BRANDEIS UNIVERSITY (US) | 2012-09-25 | — | — | US | disclosed |
| US-20100184724-A1 | COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS | GRENPHARMA LLC (US) | 2010-07-22 | — | — | US | disclosed |
| EP-0926154-B1 | NOVEL LACTOSAMINE OLIGOSACCHARIDES AND PROCESS FOR THE PREPARATION THEREOF | SEIKAGAKU KOGYO CO LTD (JP) | 2010-01-27 | — | — | EP | disclosed |
| US-7595308-B2 | Treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using organosilicon compounds such as dichlorodiethylsilane | GRENPHARMA LLC (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090203644-A1 | Compositions for treating and/or preventing diseases characterized by the presence of metal ions | GRENPHARMA LLC (US) | 2009-08-13 | — | — | US | disclosed |
| US-6365733-B1 | OLIGOSACCHARIDE PREPARED BY CLEAVING AND DESULFATING KERATIN SULFATE; ANTIINFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; ANTIMETASTATIS AGENTS | SEIKAGAKU CORPORATION (JP) | 2002-04-02 | — | — | US | disclosed |
| US-6132994-A | Lactosamine oligosaccharides and method for producing the same | SEIKAGAKU CORPORATION (JP) | 2000-10-17 | — | — | US | disclosed |
| EP-0926154-A1 | NOVEL LACTOSAMINE OLIGOSACCHARIDES AND PROCESS FOR THE PREPARATION THEREOF | SEIKAGAKU CORPORATION (JP) | 1999-06-30 | — | — | EP | disclosed |
| US-5808112-A | Preparation of cis-4-O-protected-2-cyclopentenol derivatives | HOECHST MARION ROUSSEL INC. (US) | 1998-09-15 | — | — | US | disclosed |
| US-5728899-A | Preparation of cis-4-O-protected-2-cyclopentenol derivatives | HOECHST MARION ROUSSEL INC. (US) | 1998-03-17 | — | — | US | disclosed |
| EP-0817764-A1 | PREPARATION OF CIS-4-O-PROTECTED-2-CYCLOPENTENOL DERIVATIVES | HOECHST MARION ROUSSEL, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| WO-1996030320-A1 | PREPARATION OF CIS-4-O-PROTECTED-2-CYCLOPENTENOL DERIVATIVES | HOECHST MARION ROUSSEL, INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |